Literature DB >> 19270222

Peritoneal dialysis in iran and the middle East.

Iraj Najafi1.   

Abstract

The countries of the Middle East have a cumulative population of 261.1 million and a mean gross national income per capita of US$9500. The total number of patients with end-stage renal disease (ESRD) in the Middle East is almost 100 000, the mean prevalence being 430 per million population (pmp). The first implementation of intermittent peritoneal dialysis (PD) in the Middle East occurred in Turkey in 1968; continuous ambulatory PD started in Saudi Arabia, Turkey, and Kuwait in the 1980s; and automated PD, in Turkey in 1998. The total active PD patients in the region number approximately 8170. With 5750 patients, Turkey ranks first, followed by Iran and Saudi Arabia with 1150 and 771 patients respectively. Penetration of PD with respect to the ESRD population is 7.5%, and with respect to dialysis overall is 10.2%. The dialysis rate in the region, 312 pmp, is almost half the European number of 581 pmp, with a PD prevalence of 32 pmp (range: 0 - 81 pmp). The number of active PD patients has risen dramatically in the main countries since the end of the 1990s: Turkey, to 5750 from 1030; Saudi Arabia, to 771 from 132; and Iran to 1150 from 0.

Entities:  

Mesh:

Year:  2009        PMID: 19270222

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  5 in total

1.  Global trends in rates of peritoneal dialysis.

Authors:  Arsh K Jain; Peter Blake; Peter Cordy; Amit X Garg
Journal:  J Am Soc Nephrol       Date:  2012-02-02       Impact factor: 10.121

Review 2.  Dialysis-treated end-stage kidney disease in Libya: epidemiology and risk factors.

Authors:  Fathea Abobker Goleg; Norella Chiew-Tong Kong; Ramesh Sahathevan
Journal:  Int Urol Nephrol       Date:  2014-03-27       Impact factor: 2.370

3.  Seventeen years' experience of peritoneal dialysis in Iran: first official report of the Iranian peritoneal dialysis registry.

Authors:  Iraj Najafi; Sudabeh Alatab; Shahnaz Atabak; Nader Nouri Majelan; Houshang Sanadgol; Khadijeh Makhdoomi; Mohammad Reza Ardalan; Jalal Azmandian; Abbas Shojaee; Amir Keshvari; Mostafa Hosseini
Journal:  Perit Dial Int       Date:  2013-06-03       Impact factor: 1.756

4.  Epidemiology and aetiology of dialysis-treated end-stage kidney disease in Libya.

Authors:  Wiam A Alashek; Christopher W McIntyre; Maarten W Taal
Journal:  BMC Nephrol       Date:  2012-06-08       Impact factor: 2.388

5.  The gap between estimated incidence of end-stage renal disease and use of therapy.

Authors:  Shuchi Anand; Asaf Bitton; Thomas Gaziano
Journal:  PLoS One       Date:  2013-08-30       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.